 | Up a level |
Journal Article
Frost, Nikolaj 
ORCID: 0000-0001-7452-7129, Christopoulos, Petros ORCID: 0000-0002-7966-8980, Kauffmann-Guerrero, Diego, Stratmann, Jan, Riedel, Richard, Schaefer, Monica, Alt, Jurgen, Gutz, Sylvia, Christoph, Daniel C., Laack, Eckart, Faehling, Martin, Fischer, Richard, Fenchel, Klaus, Haen, Sebastian, Heukamp, Lukas, Schulz, Christian and Griesinger, Frank
(2021).
Lorlatinib in pretreated ALK- or ROS1-positive lung cancer and impact of TP53 co-mutations: results from the German early access program.
Ther. Adv. Med. Oncol., 13.
LONDON:
SAGE PUBLICATIONS LTD.
ISSN 1758-8359
Frost, Nikolaj ORCID: 0000-0001-7452-7129, Griesinger, Frank, Hoffmann, Hans, Laenger, Florian ORCID: 0000-0003-1191-4855, Nestle, Ursula, Schuette, Wolfgang, Wolf, Juergen and Reck, Martin
(2022).
Lung Cancer in Germany.
J. Thorac. Oncol., 17 (6).
S. 742 - 751.
NEW YORK:
ELSEVIER SCIENCE INC.
ISSN 1556-1380
Roeper, Julia, Frost, Nikolaj, Wermke, Martin, Saalfeld, Felix C., Heudobler, Daniel, Pukrop, Tobias, Janning, Melanie, Kuon, Jonas, Fischer, Rieke, Nogova, Lucia, Christopoulos, Petros ORCID: 0000-0002-7966-8980 and Griesinger, Frank
(2022).
Thoracic oncology-metastatic stages.
Onkologe, 28 (SUPPL 1).
S. 55 - 61.
HEIDELBERG:
SPRINGER HEIDELBERG.
ISSN 1433-0415